Osaic Holdings’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,460
| Closed | -$255K | – | 7833 |
|
|
2025
Q3 | $255K | Sell |
5,460
-840
| -13% | -$40.7K | ﹤0.01% | 4013 |
|
|
2025
Q2 | $336K | Sell |
6,300
-160
| -2% | -$7.27K | ﹤0.01% | 3492 |
|
|
2025
Q1 | $261K | Buy |
6,460
+5,352
| +483% | +$227K | ﹤0.01% | 3424 |
|
|
2024
Q4 | $30.8K | Buy |
1,108
+8
| +0.7% | +$242 | ﹤0.01% | 5051 |
|
|
2024
Q3 | $31.6K | Hold |
1,100
| – | – | ﹤0.01% | 5074 |
|
|
2024
Q2 | $25.8K | Sell |
1,100
-1,878
| -63% | -$40.2K | ﹤0.01% | 5162 |
|
|
2024
Q1 | $75.2K | Sell |
2,978
-421
| -12% | -$10.1K | ﹤0.01% | 4451 |
|
|
2023
Q4 | $79.4K | Sell |
3,399
-1,843
| -35% | -$36.3K | ﹤0.01% | 4587 |
|
|
2023
Q3 | $265K | Buy |
5,242
+3,433
| +190% | +$160K | ﹤0.01% | 3783 |
|
|
2023
Q2 | $84.5K | Buy |
1,809
+359
| +25% | +$16.5K | ﹤0.01% | 4564 |
|
|
2023
Q1 | $55.5K | Buy |
1,450
+315
| +28% | +$14K | ﹤0.01% | 4875 |
|
|
2022
Q4 | $62K | Sell |
1,135
-289
| -20% | -$12.4K | ﹤0.01% | 4776 |
|
|
2022
Q3 | $48K | Buy |
1,424
+1,150
| +420% | +$17.6K | ﹤0.01% | 4929 |
|
|
2022
Q2 | $3K | Hold |
274
| – | – | ﹤0.01% | 6689 |
|
|
2022
Q1 | $4K | Sell |
274
-723
| -73% | -$12.7K | ﹤0.01% | 6560 |
|
|
2021
Q4 | $22K | Buy |
997
+112
| +13% | +$2.48K | ﹤0.01% | 5717 |
|
|
2021
Q3 | $19K | Hold |
885
| – | – | ﹤0.01% | 5803 |
|
|
2021
Q2 | $22K | Sell |
885
-400
| -31% | -$11.2K | ﹤0.01% | 5591 |
|
|
2021
Q1 | $37K | Buy |
+1,285
| New | +$38.9K | ﹤0.01% | 5074 |
|
Other funds holding AKRO
Osaic Holdings's AKRO Position: Q4 2025 in Review
Osaic Holdings sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 5,460 shares — an estimated $255K sold.
Osaic Holdings first reported a position in AKRO in Q1 2021 and held it in 19 quarters. The position peaked at $336K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Osaic Holdings reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 5,460 Akero Therapeutics shares in Q4 2025, an estimated $255K.
- Osaic Holdings first reported a position in Akero Therapeutics in Q1 2021 and held it in 19 quarters.
- Osaic Holdings's Akero Therapeutics position peaked at $336K in Q2 2025.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.